-transparent.png){kind=logo}
Metrizamide seems to be a suitable contrast medium for ventriculography and myelography. This contrast medium is less toxic and far less epileptogenic and spasmogenic than the other water-soluble contrast media in current use. No serious complications were noted in the present series. Transient changes in EEG were recorded, mainly with cervical myelographies. However, it is too early to evaluate the long-term side effects.
Related Publications
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1976,
Acta radiologica. Supplementum,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1959,
Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1973,
Acta radiologica. Supplementum,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1954,
Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1986,
Drug intelligence & clinical pharmacy,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
August 2004,
Zhongguo shi yan xue ye xue za zhi,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1978,
Medecine interne,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1973,
Acta radiologica. Supplementum,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
December 1969,
Indian journal of medical sciences,
O Sortland, and
A Lundervold, and
A Svare, and
E Hauglie-Hanssen
January 1981,
Neuropatologia polska,
